- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Aflibercept – July 2013
Aflibercept, injection, 4 mg/0.1 mL, Eylea®
Last updated
8 November 2023